Olema Pharmaceuticals, Inc. - stock earnings
OLMA Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -26.8 million USD | ? USD |
| 2023Q3 | -21.5 million USD | ? USD |
| 2023Q2 | -20.1 million USD | ? USD |
| 2023Q1 | -27.0 million USD | ? USD |
| 2022Q4 | -25.1 million USD | ? USD |
| 2022Q3 | -22.2 million USD | ? USD |
| 2022Q2 | -32.4 million USD | ? USD |
| 2022Q1 | -22.8 million USD | ? USD |
| 2021Q4 | -21.6 million USD | ? USD |
| 2021Q3 | -17.7 million USD | ? USD |
| 2021Q2 | -16.4 million USD | ? USD |
| 2021Q1 | -15.3 million USD | ? USD |
| 2020Q4 | -10.1 million USD | ? USD |
| 2020Q3 | -7.8 million USD | ? USD |
| 2020Q2 | -2.5 million USD | ? USD |
| 2020Q1 | -1.7 million USD | ? USD |
| 2019Q4 | -1.0 million USD | ? USD |
OLMA Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -96.7 million USD | ? USD |
| 2022 | -102.6 million USD | ? USD |
| 2021 | -70.9 million USD | ? USD |
| 2020 | -22.8 million USD | ? USD |
| 2019 | -4.3 million USD | ? USD |
| 2018 | -2.2 million USD | ? USD |
OLMA
Price: $11.24
52 week price:
Earnings Per Share: -2.14 USD
P/E Ratio: -6.75
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 106400
Market Capitalization: 596.8 million